ID
11995
Description
Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01649050
Link
https://clinicaltrials.gov/show/NCT01649050
Keywords
Versions (1)
- 8/30/15 8/30/15 -
Uploaded on
August 30, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Description
Patients with symptoms of spasticity not due to MS.
Data type
boolean
Alias
- UMLS CUI [1]
- C0026838
Description
Patients taking three or more different anti-spasticity medications.
Data type
boolean
Alias
- UMLS CUI [1]
- C0013227
- UMLS CUI [2]
- C0026838
Description
Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.
Data type
boolean
Alias
- UMLS CUI [1]
- C0235874
- UMLS CUI [2]
- C0026769
Description
Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.
Data type
boolean
Alias
- UMLS CUI [1]
- C0015980
Description
Use of baclofen pump at any time.
Data type
boolean
Alias
- UMLS CUI [1]
- C3836732
Description
Wheelchair or bed-bound patients.
Data type
boolean
Alias
- UMLS CUI [1]
- C0043143
Similar models
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
- StudyEvent: Eligibility
C0332307 (UMLS CUI [2])
C0026769 (UMLS CUI [2])
C0026769 (UMLS CUI [2])
C0026838 (UMLS CUI [2])
C0026769 (UMLS CUI [2])